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ttp://dx.doi.org/10.1016/j.ajpath.2013.04.015Coxsackievirus B3 (CVB3) variants H3 and H310A1 differ by a single nonconserved amino acid in the VP2
capsid region. C57Bl/6 mice infected with the H3 virus develop myocarditis correlating with activation
of T cells expressing the Vg4 T cell receptor chain. Infecting mice with H310A1 activates natural killer T
(NKT; mCD1d-tetramerþ TCRbþ) cells, but not Vg4 T cells, and fails to induce myocarditis. H310A1
infection preferentially activates M2 alternatively activated macrophage and CD4þFoxP3 (T regulatory)
cells, whereas CD4þTh1 (IFN-gþ) cells are suppressed. By contrast, H3 virus infection activates M1
proinﬂammatory and CD4þTh1 cells, but not T regulatory cells. The M1 macrophage show signiﬁcantly
increased CD1d expression compared to M2 macrophage. The ability of NKT cells to suppress myocarditis
was shown by adoptive transfer of puriﬁed NKT cells into H3-infected NKT knockout (Ja18 knockout)
mice, which inhibited cardiac inﬂammation and increased T regulatory cell response. Cardiac virus titers
were equivalent in all mouse strains indicating that neither Vg4 nor NKT cells participate in control of
virus infection. These data show that NKT and Vg4 cells cross-regulate T regulatory cell responses during
CVB3 infections and are the primary factor determining viral pathogenesis in this mouse model.
(Am J Pathol 2013, 183: 441e449; http://dx.doi.org/10.1016/j.ajpath.2013.04.015)Supported by NIH grants HL108371 (S.A.H.), HL093604 (S.A.H.),
HL086549 (S.A.H.), AI067897 (J.E.B.), and P20 GM103496-07 (S.A.H.
and J.E.B), and the National Science Foundation of China (30800481 to
W.L.) from the People’s Republic of China.Enteroviruses and adenoviruses cause approximately 80%
of clinical viral myocarditis in all age groups.1 Cardiac injury
results from direct viral injury to infected myocytes and also
from host immune responses triggered by the infection.2 Host
responses include: i) induction of proinﬂammatory cytokines
[IL-6, IL-1b, and tumor necrosis factor-a (TNF-a)] that
suppress myocardial cell contractility3; ii) lysis of infected
cardiocytes4; and iii) humoral or cellular autoimmunity to
heart antigens, leading to cardiocyte death or dysfunction.5e7
T-cell depletion of mice infected with coxsackievirus B3
(CVB3) dramatically reduces animal mortality and cardiac
inﬂammation,8 and heart-speciﬁc, autoimmune CD8þ T cells
isolated from CVB3-infected mice9 transfer myocarditis into
uninfected recipients. Furthermore, immunizing mice with
cardiac myosin in adjuvant causes cardiac inﬂammation
closely resembling the virus-induced disease.7,10e12 Several
studies demonstrate that induction of autoimmunity in
myocarditis corresponds to a decrease in T regulatory
cells,13,14 and T regulatory 1 (Tr1) cells making IL-10 are thestigative Pathology.
.probable suppressive effectors causing myocarditis resis-
tance in both myosin- and CVB3-induced disease.12,15,16
Recently, studies have shown that gd T cells activated
during pathological CVB3 infections are primarily respon-
sible for preventing T regulatory cell responses and directly
kill differentiated CD4þCD25þFoxP3þ T regulatory cells
through Fas-dependent mechanisms.2,17
Not all CVB3 variants cause myocarditis. Two CVB3
variants, H3 and H310A1, have been cloned and character-
ized. The H310A1 virus was isolated from the parental H3
virus using a monoclonal antibody to the viral receptor and has
a single nonconserved mutation in the VP2 capsid protein in
a puff region known for decay accelerating factor (DAF)
binding.18 Unlike the highly myocarditic H3 virus, the
Figure 1 C57Bl/6 male mice infected with either H3 or H310A1 virus.
Percentage myocardium inﬂammation and cardiac virus titer in mice
infected with either H3 or H310A1 virus (A and B). Lymphoid cells labeled
with antibodies to Vg4 TCR chain and CD69 early activation marker (C) or
with mCD1d-tetramer and antibody to TCRb for NKT cells (D). Values are
given as data from individual mice with means  SEM indicated for each
group. **P < 0.01 H310A1-infected mice versus H3-infected mice.
Liu et alH310A1 virus is amyocarditic and preferentially activates
T regulatory cells16 due to an inability to stimulate gd T cells
during H310A1 virus infections.19 As shown here, although
the gd T cell response is defective in H310A1-infected mice,
substantial numbers of natural killer T (NKT) cells are present
in the hearts of H310A1-infected, but not H3-infected,
animals. This raises the question whether NKT cells promote
the generation of T regulatory cells in the myocarditis-resistant
animals. This idea is supported by recent studies in which
CVB3-infected mice given the NKT ligand, a-galactosylcer-
amide (a-GalCer), develop signiﬁcantly less myocarditis than
untreated animals.20 This study found alterations in cytokine
environment in the a-GalCeretreated mice but did not
investigate the role of T regulatory cells in causing the anti-
inﬂammatory cytokine response.
Although somewhat controversial, various reports indicate
that NKT cells suppress autoimmunity or promote tolerance
by their effect on T regulatory cell response. Interaction of
antigen-presenting cells and NKT cells through CD1d during
oral tolerance to nickel results in secretion of IL-4 and IL-10,
and activation of T regulatory cells.21e23 Similarly, systemic
tolerance could not be established in a mouse model of
anterior chambereassociated immune deviation in CD1d
knockout (KO) mice unless the animals were transfused with
NKT cells and CD1dþ antigen-presenting cells.24 Other
studies show that aGalCer, a well-known and speciﬁc NKT
CD1d-restricted ligand, increases T regulatory cell numbers
in vivo25 and can suppress autoimmune diabetes in NOD
mice.26e28 Cytokines, such as transforming growth factor-
b (TGF-b) and IL-10, can be produced by NKT cells,29,30
which could affect dendritic cell cytokine (IL-10) and
accessory molecule (CD40, CD80, and/or CD86)
expression,31e33 leading to T regulatory cell responses.27,34
Here, studies show that NKT cells activated during
H310A1 infection cause the increased T regulatory cell
response seen in this model. These experiments show that the
nature of the innate immune response following enterovirus
infection is crucial in determining autoimmunity induction.
Materials and Methods
Mice
C57Bl/6 and C57Bl/6 d knockout (gd KO) male mice were
obtained from Jackson Laboratories, Bar Harbor ME.
C57Bl/6 Ja18 knockout (NKT KO) mice have been
described previously35 and were maintained as a breeding
colony at the University of Vermont. Male mice were used
at 5 to 8 weeks of age. All experiments were reviewed and
approved by the University of Vermont Institutional Animal
Use and Care Committee.
Virus Infection and Titration
The H3 and H310A1 variants of CVB3 have been previ-
ously described.18 Adult mice were infected by i.p. injection442with 102 plaque-forming units (PFU) of H3 or 104 PFU
H310A1 virus in PBS. Animals were sacriﬁced 7 days after
infection. Hearts were removed and then titered using
a plaque forming assay.18
Antibodies
Antibodies used in ﬂow cytometry were purchased from BD
Biosciences (San Jose, CA). The following antibodies were
used: ﬂuorescein isothiocyanate (FITC) antieT cell receptor
b (TCRb) (clone H57-597); Pe-Cy5.5 and Alexa 647 anti-
CD4 (clone GK1.5); FITC anti-CD8a (clone 53-6.7), PE
anti-interferon (IFN)-g (clone XMG1.2); FITC anti-Vg4
(clone UC3); PE anti-FoxP3 (clone FJK-16s; eBiosciences,
San Diego, CA); PerCP-Cy5.5 anti-CD69 (clone H1.2F3);
FITC or PE anti-CD1d (clone 1B1); Alexa 647 anti-CD11b
(clone M1/70); FITC antieIL-10 (clone JES5-16E3); PE
antieIL-12 (clone C17.8); biotin anti-Ly6C (clone AL-21);
PE-Cy7 streptavidin; puriﬁed Fc Block (anti-CD16/CD32,
clone 2.4G2); Pe-Cy5.5 and Alexa 647 ratIgG2b; APC-Cy7
and PE rat IgG2a (clone R35-95); FITC mouse IgG2a; and
FITC and PerCP-Cy5.5 hamster IgG (clone G235-2356). PE
mCD1d/PBS57 was supplied by the NIH Tetramer Core
Facility at Emory University (Atlanta, GA).
Flow Cytometry
Hearts were perfused with 10 mL of PBS and removed,
minced ﬁnely, and then digested with 0.4% collagenase II
(Sigma-Aldrich, St. Louis, MO) as described previously.36
The cells were centrifuged on Histopaque (Sigma-Aldrich)
for 25 minutes at 325  g and the lymphocytes removed,ajp.amjpathol.org - The American Journal of Pathology
Figure 2 Histology of C57Bl/6, NKT KO, or gd KO 5- to 8-week-old male
mice either uninfected or infected 7 days earlier with either 102 PFU H3 or
104 PFU H310A1 virus i.p. Hearts were removed, perfused with PBS,
formalin ﬁxed, parafﬁn embedded, sectioned, and then stained with H&E.
Representative examples of histology from each group are provided from
the animals reported in Figure 3A.
Figure 3 C57Bl/6 (B6), NKT KO, and gd KO mice were infected i.p. with
either 102 PFU H3 (A and C) or 104 PFU H310A1 (B and D) virus and
sacriﬁced 7 days later. Hearts were evaluated for myocarditis by image
analysis (A and B) and cardiac virus titers by the plaque forming assay (C
and D). Values represent individual mice with means  SEM of each group
indicated. **P < 0.01 infected NKT KO or gd KO mice versus B6 mice.
NKT/gd T Cells Control T Regulatory Cellswashed with PBS, and then resuspended in PBSe1%
bovine serum albumin (BSA) (Sigma-Aldrich) containing
Fc Block (dilution 1:100) and the relevant ﬂuorochrome-
labeled antibodies as indicated in the text. After incuba-
tion on ice for 30 minutes, the cells were washed in
PBS-BSA and then ﬁxed in 2% paraformaldehyde for ﬂow
cytometry. Cells were analyzed using a BD LSR II ﬂow
cytometer (BD Biosciences) with a single excitation
wavelength (488 nm) and band ﬁlters for FITC (525 nm),
PerCP-Cy5.5 (695/40 nm), and PE (575 nm). The excita-
tion wavelength for Alexa 647 is 643 nm and a band ﬁlter
of 660/20 nm. The cell population was classiﬁed for cell
size (forward scatter) and complexity (side scatter). At
least 10,000 cells were evaluated. Positive staining was
determined relative to isotype controls. To determine the
number of individual cell populations, the total number of
viable cells was determined by trypan blue exclusion.
Following ﬂow cytometry, the percentage of a subpopula-
tion staining with a speciﬁc antibody was multiplied by the
total number of cells.
Intracellular Cytokine Staining
Details for intracellular cytokine staining have been pub-
lished previously.37 Spleen cells (1  105) were cultured for
4 hours in RPMI 1640 medium containing 10% fetal bovine
serum, antibiotics, 10 mg/mL of Brefeldin A (BFA) (Sigma-
Aldrich), 50 ng/mL phorbol myristate acetate (PMA)
(Sigma-Aldrich), and 500 ng/mL ionomycin (Sigma-
Aldrich). The cells were washed in PBS-BSA containing
BFA, incubated on ice for 30 minutes in PBS-BSA-BFA
containing Fc Block (dilution 1:100) and antibodies to
CD11b and Ly6C, CD8, or CD4. The cells were washed
once with PBS-BSA-BFA, ﬁxed in 2% paraformaldehydeThe American Journal of Pathology - ajp.amjpathol.orgfor 10 minutes, and then resuspended in PBS-BSA con-
taining 0.5% saponin, Fc Block, and antibodies (dilution
1:100) to either IFN-g, IL-10, or IL-12, as indicated in the
text, for 30 minutes on ice. For FoxP3 staining, cells were
labeled with anti-CD4 in PBSe1% BSA containing Fc
Block, washed, ﬁxed, and permeabilized with the FoxP3
ﬁxative/permeability buffer set (eBiosciences), then incu-
bated with anti-FoxP3 and Fc Block for 45 minutes at 4C.
The cells were washed and then resuspended in 2%
paraformaldehyde.
Isolation of NKT and Vg4þ Cells
The basic protocol for isolation of innate cells from
inﬂammatory cells inﬁltrating the hearts of CVB3-infected
mice has been published previously.2 Basically, for isolation
of Vg4þ cells, C57Bl/6 mice were infected with H3 virus,
and for isolation of NKT cells, C57Bl/6 mice were infected
with H310A1 virus. After 7 days, hearts were perfused with
10 mL of PBS, removed, minced ﬁnely, and then pressed
through increasingly ﬁne mesh screens. The large cellular
debris was allowed to settle, and the cell suspension con-
taining the inﬂammatory cells was layered on Histopaque
(Sigma-Aldrich) and centrifuged at 300  g for 25 minutes.
The cells at the interface were retrieved, washed in
PBSe2% fetal bovine serum, and stained with PE mCD1d-
tetramer and FITC anti-TCRb for NKT cells or with PE
anti-Vg4 and FITC anti-CD69 for Vg4þ cells. The double-
positive cell populations were isolated by ﬂuorescence-
activated cell sorting sterile sorting. Cells were either
resuspended in PBS, and 0.2 mL containing 0.5  104 cells443
Figure 4 Characterization of inﬁltrating lymphoid cells in H3- and H310A1-infected mice. Lymphocytes were isolated from hearts of C57Bl/6, NKT KO, or
gd KO mice infected i.p. 7 days earlier with either 102 PFU H3 or 104 PFU H310A1. A: The total inﬁltrating lymphoid cells isolated from the heart of each
individual mouse were determined by trypan blue exclusion. Lymphoid cells from the hearts (105 cells) were stimulated with ionomycin, PMA, and BFA for 4
hours, labeled with either anti-CD4 or anti-CD8, ﬁxed, permeabilized, and then labeled with antieIFN-g to demonstrate Th1 cells (B); labeled with anti-CD4,
ﬁxed, permeabilized, and labeled with anti-FoxP3 to demonstrate T regulatory cells (C); labeled with anti-Vg4 and anti-CD69 (D); or labeled with mCD1d-
tetramer and anti-TCRb to demonstrate NKT cells (E). F: Lymphocytes were obtained from hearts of C57Bl/6 mice infected 7 days earlier with either 102
PFU H3 (for Vg4 cell isolation) or 104 PFU H310A1 (for NKT cell isolation) and labeled with either CD1d-tetramer and antibody to TCRb (for NKT cells), or with
antibody to Vg4 and CD69 (for Vg4 cells), and were then subjected to sterile sorting. The indicated cytokine evaluation was performed using commercial kits
according to the manufacturer’s directions. Values represent the number of the speciﬁc cells in the heart-derived lymphoid cell population and were
determined by multiplying the percentage of positive cells as determined by ﬂow cytometry multiplied by the number of lymphoid cells isolated from each
heart. Values represent means  SEM of 3 to 8 mice/group. **P < 0.01 H3-infected NKT KO or gd KO mice versus H3-infected B6 mice. yP < 0.05, yyP < 0.01
H310A1-infected NKT KO or gd KO mice versus H310A1-infected B6 mice. zzP < 0.01 cytokine values for Vg4 cells versus NKT cells.
Liu et alwas injected through the tail vein of anesthetized mice, or
were resuspended in RPMI 1640 medium containing 5%
fetal bovine serum, 50 ng/mL PMA, and 500 ng/mL ion-
omycin for 4 hours at 37C in a humidiﬁed CO2 incubator to
produce supernatant for analysis of cytokine. Some mice
also were injected i.p. with 200 mg of monoclonal anti-
mouse IL-4 (BD Biosciences) in 0.5 mL of PBS on the
same day as injection of virus and NKT cells.
ELISA for Cytokines
Cytokine concentrations in tissue culture supernatants were
determined for IL-4, IL-10, IFN-g, and TNF-a using
commercial enzyme-linked immunosorbent assay (ELISA)
kits for these mouse cytokines according to the manufacturer’s
directions (Invitrogen/Life Technologies, Carlsbad, CA).
Histology
The apical half of the heart was ﬁxed in 10% buffered
formalin, sectioned, and stained with H&E. Sections were
captured using a Nikon Eclipse 50i microscope and Nikon
ACT-1 software version 2.65 (Nikon Instruments, Melville,
NY). Images were analyzed using Adobe Photoshop CS5444(Adobe Systems, San Jose, CA) for the percentage of the
myocardium inﬂamed.
Statistics
The nonparametric Kruskal-Wallis test followed by the
Dunn’s post test was performed using GraphPad Prism
version 6.01 for Windows (GraphPad Software, La Jolla,
CA). This statistical analysis was used because the data
lacked Gaussian distribution.
Results
Differential Activation of NKT and Vg4 Cells in H3- and
H310A1-Infected C57Bl/6 Mice
Hearts from uninfected C57Bl/6 mice show no cardiac
inﬂammation or virus by plaque forming assay (data not
shown). C57Bl/6 mice were infected with either H3 or
H310A1 virus and sacriﬁced 7 days later. Hearts from indi-
vidual mice were evaluated for cardiac inﬂammation
(Figure 1A) and cardiac virus titers (Figure 1B). To determine
myocarditis, hearts were formalin ﬁxed, parafﬁn embedded,
sectioned, stained with H&E, and evaluated by image analysisajp.amjpathol.org - The American Journal of Pathology
Figure 5 Representative ﬂow histograms of NKT cells as indicated by
labeling with mCD1d-tetramer and anti-TCRb and Vg4þCD69þ cells in B6,
NKT KO, and gd KO mice infected with H3 virus 7 days earlier.
NKT/gd T Cells Control T Regulatory Cellsas published previously.18 Additional mice were infected, the
hearts removed, and the mononuclear cell population retrieved
for analysis of T cells expressing TCR Vg4 and CD69 (early
activation marker) (Figure 1C) or were labeled with anti-
TCRb chain and mCD1d-tetramer as indicative of invariant
natural killer T (iNKT) cells (Figure 1D). There was no
signiﬁcant difference in cardiac virus titers between the
groups; however, myocarditis was signiﬁcantly more severe in
H3- than in H310A1-infected mice. As shown previously,38
increased myocarditis in H3-infected animals correlated to
substantial numbers of Vg4þ T cells inﬁltrating the heart,
whereas these cells were absent in H310A1-infected animals.
Evaluation of iNKT cell response in CVB3 infection had not
been done previously, but the current data show that iNKT
cells only inﬁltrate the heart in H310A1-infected, but not in
H3-infected, mice.
The results shown in Figure 1 give circumstantial evidence
that iNKT and Vg4 cells have distinct roles in myocarditis,
with iNKT cells protecting and Vg4 cells promoting disease.
To further conﬁrm the divergent roles for these two innate
effector T cells, mice deﬁcient in either cell population (NKT
KO or gdKO) were infected with either H3 or H310A1 virus
(Figures 2 and 3). Figure 2 shows the representative histology
of hearts from C57Bl/6, NKT KO, and gd KO mice infected
7 days earlier with either 102 PFU H3 or 104 PFU H310A1
virus. Figure 3A shows the percentage of the myocardium
inﬂamed for all mice in each group and shows that H3 virus
induced substantial cardiac inﬂammation in wild-type and
iNKT KO mice, but not in mice lacking gd T cells, despite
statistically equivalent cardiac virus titers in all three groups
of mice (Figure 3C). Neither wild-type nor gd KO mice
infected with H310A1 virus showed substantial myocarditis
(Figure 3B). However, H310A1 virus infection of iNKT KO
mice induced similar levels of cardiac inﬂammation as
observed in H3-infected wild-type mice. Figure 4 shows the
various lymphoid cell populations found in the hearts of H3-
and H310A1-infected C57Bl/6, NKT KO, and gd KO mice.
In mice developing myocarditis (H3-infected C57Bl/6, H3-
infected NKT KO, and H310A1-infected NKT KO mice),
increased numbers of total inﬁltrating lymphoid cells
(Figure 4A), CD4þIFN-gþ, and CD8þIFN-gþ (Figure 4B)
and reduced numbers of T regulatory cells (CD4þFoxP3þ)
(Figure 4C) were found, whereas mice resistant to myocar-
ditis (H3-infected gdKO, H310A1-infected C57Bl/6, and gd
KO) had reduced T helper 1 (Th1) cells and T regulatory
cells. Figure 4, D and E, conﬁrms the absence of Vg4 and
NKT cells in respective gd KO and iNKT KO mice. One
question remained as to what cytokines are expressed by
NKT and gd T cells subsequent to CVB3 infection and
whether these cytokines might impact T regulatory cell
activation. To address this question, NKT and Vg4 T cells
were isolated by sterile sorting based on CD1d-tetramer/
TCRb double-positive staining (Figure 5) or Vg4/CD69
double-positive staining and cultured for 4 hours in medium
containing PMA/ionomycin but without BFA. The super-
natants were isolated and analyzed by ELISA for IL-4, IL-10,The American Journal of Pathology - ajp.amjpathol.orgIFN-g, and TNF-a as these were considered to be the best
candidate cytokines mediating positive or negative effects on
proinﬂammatory responses. Figure 4F shows that NKT cells
produced signiﬁcant amounts of IL-4 (105  33 mg/mL), but
no other cytokine tested. Vg4 T cells produced negligible
amounts of IL-10 and IL-4 but produced signiﬁcant amounts
of IFN-g and TNF-a. Representative ﬂow histograms are
shown in Figure 5 for Vg4þ and NKT cell populations.
Besides T cells, the other predominant lymphoid cell
population found in the heart is the macrophage/monocyte.
Analysis of classically activated (inﬂammatory; M1) and
alternatively activated (M2) macrophages was performed by
gating on CD11bþLy6Chi cells and evaluating IL-12 and IL-
10 expression by intracellular cytokine staining (Figure 6).
When infected with H3 virus, both C57Bl/6 and NKT KO
mice showed a polarization toward the M1 macrophage
phenotype (CD11bþLy6ChiIL-12þ), whereas gd KO mice
showed polarization toward alternatively activated M2
macrophage (CD11bþLy6ChiIL-10þ) (Figure 6A). When
C57Bl/6 mice were infected with H310A1 virus, the number
of CD11bþLyChiIL-10þ cells increased (Figure 6B),
whereas the number of CD11bþLyChiIL-12þ cells was
signiﬁcantly reduced (Figure 6B). CD11bþLyChiIL-10þ
cells in NKT KO mice were also reduced. To conﬁrm that
NKT cells are determining M2 macrophage phenotype, NKT
cells were isolated by sorting from hearts of H310A1-
infected C57Bl/6 mice, and 0.5  104 cells were injected
i.v. through the tail vein into NKT KO recipients that were
infected with H310A1 virus on the same day as cell transfer.
An additional group of NKT KO mice given NKT cells was
also given 200 mg of monoclonal antieIL-4 on the same day
as NKT cell transfer because this has been shown to reverse445
Liu et althe ability of NKT cells to polarize macrophage to the M2
phenotype.39 As shown in Figure 6B, reconstitution of mice
with NKT cells increased M2 macrophage inﬁltrating the
heart, but treatment of mice with antieIL-4 in addition to
administration of NKT cells abrogated this effect.
Figure 6C shows that C57Bl/6 mice infected with
H310A1 virus develop minimal myocarditis, whereas
similarly infected NKT KO mice develop increased
myocarditis as also shown in Figure 3. Providing NKT KO
mice NKT cells abrogated the increase in myocarditis,
conﬁrming the protective effect of this population in
myocarditis. However, administration of antieIL-4 in
addition to NKT cells again resulted in increased myocar-
ditis. No differences in cardiac virus titers were observed
between any of the groups (Figure 6D). The number of
CD4þFoxP3þ T regulatory cells isolated from the hearts of
the mice generally correlated with myocarditis, because
numbers of these immunoregulatory cells were increased in
H310A1-infected C57Bl/6 mice and NKT KO mice recon-
stituted with NKT cells, but not in NKT KO mice or NKTFigure 6 Macrophage phenotype and innate effector cells. A: C57Bl/6, NKT KO
the lymphoid cells inﬁltrating the hearts of individual mice were retrieved and e
antibody to CD11b and Ly6C, ﬁxed, permeabilized, and then labeled with antibodi
versus IL-12þ macrophage. B: C57Bl/6 and NKT KO mice were infected with 104
puriﬁed NKT cells i.v. through the tail vein. The NKT cells were isolated by ﬂow
trating the hearts of C57Bl/6 mice infected 7 days earlier with 104 PFU H310A1 a
mice given NKT cells also was injected i.p. with 200 mg of monoclonal antieIL-4. N
sacriﬁced 7 days later, and lymphoid cells inﬁltrating the hearts were retrieved a
macrophage, C57Bl/6 only). *P < 0.05, **P < 0.01 versus C57Bl/6 IL-10þ cells
antieIL-4 as represented in B were evaluated for percent myocardium inﬂamed (C
0.05, **P < 0.01 versus C57Bl/6 mice. yP < 0.05 versus NKT KO and NKT KO þ NKT
cells from individual mice with the means  SEM for each group indicated.
446KO þ NKT cellereconstituted animals given antieIL-4
(Figure 6E). There were signiﬁcantly fewer T regulatory
cells in the latter group than in C57Bl/6 mice despite the fact
that both of these groups show minimal myocarditis.Role of CD1d Expression Levels in NKT and Vg4þ Cell
Activation
Previous studies have shown that H3 infection up-regulates
CD1d expression on cardiac myocytes and endothelial cells
to a greater extent than H310A1 virus.38 To evaluate the
effect of H3 and H310A1 infection on CD1d expression on
monocytes, lymphoid cells inﬁltrating the hearts of H3- and
H310A1-infected C57Bl/6 mice were isolated, gated on the
CD3-CD11bþ subpopulation, and evaluated for CD1d
expression (Figure 7A). Both the percent CD1dþ CD11bþ
cells (Figure 7B) and mean ﬂuorescence intensity of CD1d
on the CD11bþ cells (Figure 7C) were signiﬁcantly
increased with H3 compared to H310A1 infection., and gd KO mice were infected i.p. with 102 PFU H3 virus 7 days earlier, and
valuated for M1 or M2 macrophage phenotype. The cells were labeled with
es to IL-10 (M2) or IL-12 (M1). *P < 0.05, **P < 0.01 IL-10þ macrophage
PFU H310A1 i.p. Groups of infected NKT KO mice also received 0.5  104
sorting of doubly labeled mCD1d-tetramer/anti-TCRbþ lymphoid cells inﬁl-
s described in Figure 4 and in Materials and Methods. One group of NKT KO
KT cells and antieIL-4 were injected on the same day as virus. All mice were
nd evaluated for CD11b, Ly6Chi, and IL-10 (M2 macrophage) or IL-12 (M1
. Replicate groups of H310A1-infected mice with or without NKT cells and
), cardiac virus titers (D), and number of CD4þFoxP3þ cells/heart (E). *P <
cells þ antieIL-4 groups. Values represent number of cells in the lymphoid
ajp.amjpathol.org - The American Journal of Pathology
NKT/gd T Cells Control T Regulatory CellsDiscussion
Our results demonstrate a reciprocal activation pattern
between gd and NKT cells subsequent to infection with two
CVB3 variants that differ by a single nonconserved amino
acid in a region of the VP2 capsid protein known to bind
DAF, one of the two cellular molecules capable of acting as
virus receptors.18,40 Although prior studies have shown that
the H3 and H310A1 variants of CVB3 are myocarditic and
amyocarditic in mice, respectively, and that the poor path-
ogenicity of the H310A1 variant results from the inability of
the virus to activate a subpopulation of gd T cells
expressing the Vg4 chain,19,38 these studies had not inves-
tigated NKT cell responses or the role of these effectors in T
regulatory cell activation. A prior publication20 had
demonstrated that a-GalCer treatment of CVB3-infected
mice protects against myocarditis; causes increases in
IFN-g and IL-4, but decreases in TNF-a, IL-6, MIP2, and
MCP-1 expression; and decreased virus replication. Because
a-GalCer is accepted as a speciﬁc iNKT cell agonist, this
study indicated that activation of these innate effectors are
potentially protective in myocarditis. However, a-GalCer,
derived from sea sponge, is both a highly potent and
somewhat artiﬁcial activator of NKT cells, and therefore,
the study does not prove that NKT cells activated during
a speciﬁc viral infection would be equally protective. The
signiﬁcance of our ﬁndings is that they show that NKT cell
activation in the course of a natural CVB3 infection is
sufﬁcient to prevent myocarditis; that there is an inverse
relationship between activation of two CD1d-speciﬁc innateFigure 7 CD1d expression on CD11bþ cells isolated from the heart.
C57Bl/6 mice were infected 7 days earlier with either H3 or H310A1 virus.
Lymphoid cells inﬁltrating the heart were labeled with antibodies to CD3,
CD11b, and CD1d. A: Representative histograms of ﬂow analysis of CD3-
CD11bþ cells for CD1d expression. B: Percent CD11bþ cells that are also
CD1dþ. C: Mean ﬂuorescence intensity of CD1d on CD11bþ cells. Data
represent means  SEM of 4 to 6 mice/group. *P < 0.05, **P < 0.01
H310A1-infected (white bars) mice versus H3-infected (black bars) mice.
The American Journal of Pathology - ajp.amjpathol.orgeffector cells (NKT and Vg4þ cells)38,41; that NKT cell
response is correlated to activation of the M2 alternatively
activated macrophage, whereas Vg4þ cells correspond to
activation of the proinﬂammatory M1 macrophage; and that
NKT cells promote T regulatory cell response, whereas
Vg4þ cells prevent T regulatory cell response. Furthermore,
in this model of CVB3 myocarditis, neither Vg4þ nor NKT
cells have a discernible role in controlling virus replication,
because cardiac virus titers are equivalent both in NKT KO
and gd KO compared to B6 mice.
A major question raised by these results is why is there such
a dramatic difference in gd and NKT cell responses between
H3- and H310A1-infected mice. Despite only a single non-
conserved amino acid difference between the two viruses,18
H3 virus basically fails to promote a strong NKT cell
response, whereas H310A1 virus does. By contrast, H310A1
infection causes a pronounced NKT cell response even though
cardiac virus titers are equivalent to those produced by the H3
virus. The mutated amino acid occurred in a VP2 capsid
protein puff region implicated in virus binding to DAF40 and
binding avidity of H310A1 to cells is signiﬁcantly reduced
compared to H3 virus using competitive binding assays. DAF
is a GPI (glycosylphosphatidylinisotol)-anchored membrane
protein and is known to affect T cell activation42,43 although
signaling through this molecule is likely to have multiple other
effects as well. Many cells in the immune system express
DAF, making them all potential targets for virus-induced
signaling through this molecule. In fact, because lymphoid
cells lack coxsackievirus and adenovirus receptor (CAR), the
other known CVB3 receptor, DAF is the most likely method
for infection of most (noneB cell) lymphoid cell pop-
ulations.44 Antibody cross-linking of DAF on T cells activates
protein tyrosine kinases p56lck and p59fyn, early factors in the
CD3-TCR pathway.45,46 However, the effect of DAF
signaling in antigen-presenting cells may be more relevant
because studies indicate that signaling through this molecule
alters programmed cell death 1 ligand 1 (PD-L1) and CD40
expression,43 and both molecules are known to affect
myocarditis susceptibility.47,48 Furthermore, we show that H3
up-regulates CD1d expression on CD11bþ cells much more
than H310A1 virus does (Figure 7). CD1d is the target antigen
recognized by both NKT and Vg4 T cells.38,49e52
The effect on CD1d expression on lymphoid cells is
consistent with previous studies showing that H3 induces
greater CD1d expression in cardiac myocytes and endo-
thelial cells than H310A1.38 These previous studies showed
that CVB3 binding to DAF caused rapid calcium ﬂux and
activation of nuclear factor of activated T-cells (NFAT), an
important transcription factor in inﬂammation.53 Interest-
ingly, only the H3 or myocarditic variant of CVB3 induced
calcium ﬂux or activated NFAT, whereas H310A1, the
nonmyocarditic CVB3 variant, failed to stimulate both
calcium ﬂux and NFAT translocation. The virus effect and
NFAT activation were clearly mediated through DAF
because DAF/ cells failed to respond to H3 virus or
activate NFAT although the virus was capable of infecting447
Liu et alDAF/ cells. The demonstration that CVB3 could infect
DAF/ cells was unexpected because, presumably, CAR,
the other major CVB3 receptor, is not expressed by
lymphoid cells. This observation was not followed up but
indicates that CAR is in fact expressed on these cells or that
other virus receptors exist on lymphoid cells. Nonetheless,
up-regulation of CD1d depended on calcium signaling and
NFAT translocation, and this speciﬁc aspect of DAF
signaling is undoubtedly responsible for modulation of
CD1d expression subsequent to H3 infection.
Because alterations in costimulatory molecule expression
on dendritic cells have been shown to promote tolerance,54,55
it is highly likely that differences in H3 and H310A1 binding
avidity to DAF alters both costimulatory molecule and CD1d
expression in antigen-presenting cells, leading to the differ-
ence in T regulatory cell activation. The relative expression
levels of CD1d may also be important. Although both NKT
and Vg4 T cells recognize CD1d, there is no evidence that
these two innate effectors are activated by the same threshold
of CD1d expression. One potential explanation for the
difference in innate response between H3 and H310A1
infections would be that NKT cells can be activated at lower
CD1d expression levels than Vg4 cells. In this case, the lower
CD1d expression observed during H310A1 infections would
be adequate to activate NKT cells but would be insufﬁcient to
activate Vg4 cells. Only infections resulting in quite high
CD1d expression patterns would stimulate the Vg4 effectors
and once activated, these effectors might down-regulate or
otherwise negate the immunomodulatory effects of the NKT
cells. Whether this hypothesis is relevant will require further
investigation. One surprising observation was that the
number of T regulatory cells recoverable from the hearts of
NKT KO mice given NKT cells was signiﬁcantly less than
that from C57Bl/6 mice (Figure 6E) despite the fact that
myocarditis in both groups was equivalent (Figure 6C). The
two likely explanations for this ﬁnding are that a minimal
number of T regulatory cells are needed to inhibit cardiac
inﬂammation, and once that threshold number is reached, any
more T regulatory cells will not further suppress inﬂamma-
tion; or there are other immunoregulatory factors in H310A1-
infected NKT KO þ NKT celletreated mice besides
T regulatory cells, which suppress myocarditis.Acknowledgments
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